Dr. Sarbajit Mukherjee is the Chief of Gastrointestinal Medical Oncology at Miami Cancer Institute in Miami, FL. Dr. Mukherjee’s current work focuses on novel clinical trials in GI malignancies. He has conducted multiple investigator-initiated clinical trials as a principal investigator. Dr. Mukherjee has received peer-reviewed grants from the Department of Defense, National Comprehensive Cancer Network (NCCN), and North American Neuroendocrine Tumor Society. He has presented at many national and international conferences and has been published in high-impact journals like Nature Medicine and the Journal of Clinical Oncology. He has served on grant review panels through the NIH (National Institutes of Health) and the US FDA.

Dr. Mukherjee co-chairs the GI clinical trial working group at the Hoosier Cancer Research Network. He also serves as a board member at the Esophageal Cancer Action Network. Dr. Mukherjee served the American Society of Clinical Oncology (ASCO) as a member of the Trainee Council Working Group, the Clinical Practice Guidelines Committee, and the Professional Development Committee. He also served on multiple guidelines panels for ASCO, NCCN and the International Society of the Diseases of the Esophagus. He has received many awards, including membership in Alpha Omega Alpha Medical Honor Society and the Gold Humanism Honor Society. Dr. Mukherjee is invested in teaching and mentoring his junior colleagues and organizing and moderating educational and scientific meetings.